Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines
- PMID: 1284126
Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines
Abstract
The effect of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) and the cytokines interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-alpha) on matrix metalloproteinases (MMP) and metalloproteinase inhibitors was studied in a variety of human cell lines. Expression of the mammalian collagenase (MMP-1), 72-kD gelatinase/type IV collagenase (MMP-2), stromelysin (MMP-3), 92-kD gelatinase/type IV collagenase (MMP-9), and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) was assessed by zymography and Northern blot analysis. MMP-2 and TIMP-2 activities were refractory to TPA, IL-1 and TNF-alpha treatment in most of the cell lines. In contrast, MMP-3, MMP-9 and TIMP-1 activities were markedly stimulated by TPA in most of the tumor cell lines and human umbilical vein endothelial cells (HUVEC), whereas the fibroblast lines were minimally stimulated or unresponsive to TPA. The MMP-3, MMP-9 and TIMP-1 stimulation in response to IL-1 and TNF-alpha treatment was detected in some of the tumor cell lines and HUVEC. The increase in activity was less marked than in TPA. A breast carcinoma cell line, MDA-MB-231, which did not express MMP-2, had high expression of MMP-3 and MMP-9 which were unaffected by TPA and cytokine treatment. Northern blot analysis of MMP and TIMP mRNA expression reflected the zymogram findings for most of the cell lines. TPA-mediated stimulation of MMP-1 was similar to that of MMP-3 and MMP-9. Exceptions were the fibroblast cell lines which showed either a much more marked mRNA response of MMP-9 to TPA than observed at protein level, or a high constitutive MMP-9 mRNA when MMP-9 activity was not detectable by zymography. TPA-mediated stimulation of MMP-9 and TIMP-1 activity was blocked by staurosporine, an inhibitor of protein kinase C (PKC). A non-PKC-activating phorbol ester, 4 alpha-phorbol-12,13-didecanoate, did not stimulate MMP-9 and TIMP-1 activity. TPA treatment caused the increased expression of c-fos containing AP-1-specific binding activity in selected tumor cell lines. This activity was maximal at 6 h. An association was observed between AP-1 binding activity and increased expression of MMP-1, MMP-3 and MMP-9, which possess TPA-responsive elements (TRE). TPA-sensitive MMPs and TIMP-1 were variably stimulated by biologically relevant cytokines, such as IL-1 and TNF-alpha.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Regulation of collagenase, stromelysin, and gelatinase B in human conjunctival and conjunctivochalasis fibroblasts by interleukin-1beta and tumor necrosis factor-alpha.Invest Ophthalmol Vis Sci. 2000 Sep;41(10):2922-9. Invest Ophthalmol Vis Sci. 2000. PMID: 10967046
-
Induction of dental pulp fibroblast matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 gene expression by interleukin-1alpha and tumor necrosis factor-alpha through a prostaglandin-dependent pathway.J Endod. 2001 Mar;27(3):185-9. doi: 10.1097/00004770-200103000-00012. J Endod. 2001. PMID: 11487149
-
Coordinate regulation of matrix metalloproteases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts.J Rheumatol Suppl. 1995 Feb;43:123-8. J Rheumatol Suppl. 1995. PMID: 7752115
-
[Gene expression of MMPs and TIMPs in the process of hepatic fibrosis].Nihon Rinsho. 1993 Feb;51(2):428-34. Nihon Rinsho. 1993. PMID: 8464157 Review. Japanese.
-
Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation.Oral Dis. 1996 Mar;2(1):70-6. doi: 10.1111/j.1601-0825.1996.tb00206.x. Oral Dis. 1996. PMID: 8957940 Review.
Cited by
-
Glioma expansion in collagen I matrices: analyzing collagen concentration-dependent growth and motility patterns.Biophys J. 2005 Jul;89(1):635-50. doi: 10.1529/biophysj.105.061994. Epub 2005 Apr 22. Biophys J. 2005. PMID: 15849239 Free PMC article.
-
The IGF-I receptor can alter the matrix metalloproteinase repertoire of tumor cells through transcriptional regulation of PKC-{alpha}.Mol Endocrinol. 2009 Dec;23(12):2013-25. doi: 10.1210/me.2009-0197. Epub 2009 Oct 23. Mol Endocrinol. 2009. PMID: 19855090 Free PMC article.
-
Significance of membrane type 1 matrix metalloproteinase expression in breast cancer.Jpn J Cancer Res. 1999 May;90(5):516-22. doi: 10.1111/j.1349-7006.1999.tb00778.x. Jpn J Cancer Res. 1999. PMID: 10391091 Free PMC article. Clinical Trial.
-
Lipid alterations in experimental murine colitis: role of ceramide and imipramine for matrix metalloproteinase-1 expression.PLoS One. 2009 Sep 29;4(9):e7197. doi: 10.1371/journal.pone.0007197. PLoS One. 2009. PMID: 19787068 Free PMC article.
-
Triptolide inhibits matrix metalloproteinase-9 expression and invasion of breast cancer cells through the inhibition of NF-κB and AP-1 signaling pathways.Oncol Lett. 2021 Jul;22(1):562. doi: 10.3892/ol.2021.12823. Epub 2021 May 27. Oncol Lett. 2021. PMID: 34093777 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous